PCU Tri-Axis Balanced Series IV-NP

Brassica nigra

Black Mustard

Tier IVPCU Tri-Axis Balanced Series

Target Trait

2.13×

fold-change

Sharp+Cooling+Umami balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-01070

Genomic Edits

GC Content

44.8%

Construct Length

5,678 bp

Promoter System

Lipid nanoparticle / Ubiquitin

Expression System

Nanoparticle delivery

Host Strain

LNP-mediated

Receptor Target

TRPA1 + TRPM8 + mGluR1

IFI Score

213

Pathway Edits

TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent PCU pathway operation
Cross-pathway regulatory circuit for balanced PCU triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPA1, TRPM8, and mGluR1 pathways simultaneously engineeredBalanced tri-axis expression strategy (PCU) with cross-pathway flux managementLNP-mediated delivery of triple-axis mRNA panel for transient expression profiling

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier IV PCU triple-axis construct for advanced multi-modal sensory architecture combining sharp, cooling, and umami axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$4249 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities